Skip to main content

Call for Papers: Medical and Surgical Treatment of Obesity to Improve Reproductive Health

Edited by:
Dr. Samantha Schon, MD, MTR, University of Michigan, United States


Submission Status: Open until 31 January 2025

2023 CiteScore Update

We are delighted to announce our 2023 CiteScore of 7.9! Reproductive Biology and Endocrinology remains firmly in Q1 within the Obstetrics & Gynecology and Reproductive Medicine categories. New Content Item


Featured Article Collection: AI in IVF and Embryology Lab

AI has the potential to revolutionize the field of IVF by improving the accuracy of embryo selection, personalizing treatment plans, and developing new technologies. This article collection, edited by Dr Zaher Merhi & Dr Marco Mouanness aims to further research on the benefits and limitations of AI in IVF, and to help ensure that its use is ethical and safe.

Celebrating World IVF Day 2023

New Content Item

Join us in commemorating World IVF Day on July 25th with a look back at the most influential articles published in Reproductive Biology and Endocrinology on IVF and assisted reproductive technology in the last few years. 

Aims and scope

Reproductive Biology and Endocrinology publishes and disseminates high-quality results from excellent research in the reproductive sciences.

The journal publishes on topics covering gametogenesis, fertilization, early embryonic development, embryo-uterus interaction, reproductive development, pregnancy, uterine biology, endocrinology of reproduction, control of reproduction, reproductive immunology, neuroendocrinology, and human reproductive medicine. 

We will consider manuscripts examining non-human primates, rats, and mice if they inform the human condition. However, we will no longer review studies involving horses, dogs, sheep, cats, cows, pigs, birds, or fish.

Follow us on Twitter at @RBEJournal!Twitter logo © Twitter

Read more about the scope here

Editor profiles

Co-Editor-in-Chief, David B Seifer

David B. Seifer is a Professor of Obstetrics & Gynecology at Yale School of Medicine in the Division of Reproductive Endocrinology and Infertility at Yale New Haven Hospital Medical Center in New Haven, CT (USA). Dr. Seifer is a consultant for the Food and Drug Administration (USA) and has published over 150 medical studies in peer-reviewed journals.

His translational research has focused upon the biology of ovarian function, particularly the aging ovary. This research has resulted in a better understanding of normal and abnormal follicular development during ART and in identifying novel human ovarian growth factors (ie. neurotrophins, inhibin B and AMH) which inform the clinical practice of reproductive medicine. His clinical research has focused upon health care disparities among women with infertility and the role of vitamin D in female reproductive health and polycystic ovarian syndrome.

Co-Editor-in-Chief, Raoul Orvieto

Raoul Orvieto is a full professor of Obstetrics and Gynecology and incumbent of the Tarnesby-Tarnowski Chair for Family Planning and Fertility Regulation, at the Faculty of Medicine, Tel-Aviv University, Israel. Prof Orvieto is the director of the Division of Reproductive Endocrinology and Infertility, at the Sheba (Tel-Hashomer) Medical Center, Israel. Since 2022, Prof. Orvieto is the president of the Israel Fertility association (IFA). Prof Orvieto is co-Editor-in-Chief of Reproductive Biology and Endocrinology. He has been author and co-author of more than 400 publications in national and international journals. His scientific interests include various aspects of controlled ovarian hyperstimulation (COH); the role of GnRH-analogues, and specifically GnRH agonist versus antagonist in COH for IVF, pre-implantation genetic testing (PGT), triggering final follicular maturation; and several aspects of ovarian hyperstimulation syndrome (OHSS): pathophysiology, prediction, prevention and its relation to the inflammatory response. See a full publication history here.

Annual Journal Metrics

  • 2022 Citation Impact
    4.4 - 2-year Impact Factor
    5.3 - 5-year Impact Factor
    1.429 - SNIP (Source Normalized Impact per Paper)
    1.059 - SJR (SCImago Journal Rank)

    2023 Speed
    7 days submission to first editorial decision for all manuscripts (Median)
    74 days submission to accept (Median)

    2023 Usage 
    1,347 Altmetric mentions